225Ac/213Bi radionuclide generators for the separation of 213Bi towards clinical demands

Hongshan Zhu, Stephan Heinitz, Koen Binnemans, Steven Mullens, Thomas Cardinaels

Research outputpeer-review

Abstract

Bismuth-213 (213Bi) is a promising radionuclide for clinical application in targeted alpha therapy of cancers. 225Ac/213Bi radionuclide generators are of particular interest for the production/separation of 213Bi. This review aims to give an overview of the current status of 225Ac production, 225Ac/213Bi radionuclide generator systems, the types of adsorbents, separation conditions, separation mechanisms, and critical challenges. The review also provides guidance for investigating emerging new sorbents that can be developed to overcome the limitations of currently used sorbents.

Original languageEnglish
Pages (from-to)4499-4527
Number of pages29
JournalInorganic Chemistry Frontiers
Volume11
Issue number15
DOIs
StatePublished - 10 Jun 2024

ASJC Scopus subject areas

  • Inorganic Chemistry

Cite this